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Schizophrenia: A Concept
Haider A. Naqvi
Department of Psychiatry, Aga Khan University, Karachi.
Abstract
Much of the current research-work into biological
basis of mental disorders is predicted on implicit concept of
disease that is less critical and sophisticated as it should be.
It is remarkable, how the fundamental conceptual frame
work of schizophrenia, as proposed by Professor Emil
Kraepelin has stayed the same, since its inception almost
100-years ago. This review explores these issues besides
highlighting alternative disease classification that suits
behavioural neuroscience research.
Introduction
Schizophrenia is one of the few syndromes that have
managed to keep itself veiled in scientific mystery, even
after 100-years of research and inquiry.  Labeled as grave
yard of psychiatry; it has generated much controversy with
plethora of theories and hypothesis attempting to answer
many questions. It is remarkable that many of the current
research ideas are in fact, rediscoveries, of early
observations and hypotheses, many of them datable to the
first decade following the Professor Emil Kraepelin's
diagnostic scheme in 1896.1
This review aims to explore the different themes
pertinent to nosology, epidemiology and research of
Schizophrenia. It intentionally aims to violate the traditional
boundaries of neurology and Psychiatry in order to embrace
an interdisciplinary perspective.  Firstly, we will examine
the historical perspective regarding the concept and
epidemiology followed by discussion on current and
alternative conceptualization of schizophrenia.
Historical aspect of Schizophrenia concept
Madness is mentioned in ancient texts such as the
Hindu Ayur Veda and the Old and New Testament. In the
writings dating from the second century AD of Aretaeus the
Cappadocian it is discussed at length. However, although
the descriptions of melancholia and its switch into hilarity
are easy to recognize, as what would now be called Bipolar
affective disorder. First unambiguous description of
symptoms suggestive of schizophrenia was given by
Haslam and by Pinel in 1809. Throughout the nineteenth
century many attempts were made to classify insanity. In
1856 Morel introduced the term dementia precox to
describe an adolescent patient once bright and active, who
had slowly lapsed into a state of withdrawal.1
Many other psychiatrists wrote descriptive accounts
of the clinical pictures presented by their psychotic patients
but in 1890 Emil Kraepelin2, Professor of Psychiatry in
Heidelberg and Munich, went beyond straightforward
clinical description and divided the broad class of functional
psychoses into two categories, essentially on the basis of
outcome. The first category, which he called manic-
depressive insanity, pursued a fluctuating course with
frequent relapses but with full recovery between episodes.
The second, for whom he used Morel's term dementia
praecox, embraced catatonia as described by Kahlbaum
(1874), hebephrenia which had been described by Hecker
(1871) and his own dementia paranoids.2 Kraepelin grouped
these together as different manifestations of a progressive
disease which either pursued a steady downhill course to a
state of chronic impairment, or if improvement did occur
resulted only in partial recovery. In grouping together the
mental illnesses of early adult life associated with poor
outcome, Kraepelin considered that he was defining a
clinical syndrome which represented a disease of the brain
the nature of which would be revealed by appropriate
investigations.
In 1911 Eugen Bleuler published his Dementia
praecox or the group of schizophrenias and it is his term of
schizophrenia that has received general acceptance.
Although Bleuler considered that he was developing
Kraepelin's concept in fact he changed it substantially.3
Bleuler was influenced by psychoanalytic schools of
thought and described the concept of schizophrenia in
psychological terms as much as in the neuropathlogical one,
as envisaged by Kraepelin. His term schizophrenia,
meaning split mind, was intended to describe what he called
a loosening of the associations between the different
functions of the mind so that thoughts became disconnected
and the coordination between emotional, cognitive and
volitional processes became poor. He considered thought
disorder, affective disturbance, autism, and ambivalence to
be the fundamental symptoms of schizophrenia and that the
more clear-cut phenomena of hallucinations, delusions, and
catatonic features emphasized by Kraepelin were of lesser
importance. This view led him to conclude that
schizophrenia could be diagnosed when there was no
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evidence that hallucinations or delusions had over occurred
and he thus added simple schizophrenia to the hebephrenic,
catatonic, and paranoid forms recognized by Kraeplin.3
These findings and others have encouraged the
formulation of operational rules for defining schizophrenia.
Such systems specify whether or not an individual patient
will be placed within that particular definition of
schizophrenia according to the presence or absence of a
given set of features. In spite of Bleuler's views, in the last
20 years, the diagnosis of schizophrenia has generally been
considered only in the presence of psychotic features, i.e.
delusions, misperceptions, and/ or thought disorder. 
Once these features are present, three separate areas
of dysfunction may be used in making the decision that a
patient has schizophrenia (Table 1). Symptoms of the first
rank (also known as unclear symptoms) were defined by
Kurt Schneider (Table 2).4
According to Schneider these symptoms by
themselves could identify an illness as unequivocally
schizophrenic. However the force of this assertion was
somewhat diminished by the recognition that they can occur
in some other conditions such as amphetamine psychosis
and the psychoses of temporal lobe epilepsy. Although
Schneider denied that these symptoms necessarily had a
particular significance in relation to the nature of the disease
process and indeed regarded them merely as a pragmatic
basis for diagnosis, several symptoms relate to the
peculiarly schizophrenic experience in which the contents
of consciousness can arise from or be directly influenced by
agencies other than the self. 
Epidemiology: Past and present 
It is of interest to note how early epidemiological
studies of schizophrenia were actually conducted 'in the
field'. The majority were carried out single-handedly by
dedicated researchers who typically spent months and
sometimes years in a community, collecting information
and interviewing, literally, door-to-door. For example,
Graemiger (1931), a Swiss general practitioner working in
rural community, published 66 extended genealogies
segregating psychotic illnesses and claimed to have known
personally 1357 of their members across four generations.
Personal knowledge of respondents, access to
multigenerational records from the local Parish registers,
and generous cooperation by the community as a whole
resulted in detailed and accurate data of a descriptive quality
that would be difficult to match today.5
Probably, the first application of the epidemiological
method in a modern sense, to the investigate psychosis was
the work of female physician, Jenny Koler, who in 1895
conducted a case-control study on the aggregation of
psychiatric disorders in the families of 284 probands and
370 healthy control subjects in Zurich (Koller, 1895). In
many ways, her conclusion anticipated present day
knowledge about genetic epidemiology of psychosis. She
found that 'the hereditary loading of healthy subjects is
much higher than generally assumed'; that 'the strongest
loading is that of psychosis and accentuated characters'; and
that 'the loading in distant relatives is quite low, unless a
person at risk is exposed to multiple factors'.6
Many of the results of those early studies retain their
benchmark value today. As a matter of fact, none of the
more recent contributions from the epidemiological
research has substantially altered the conclusions of the
earlier studies. These include the population incidence and
prevalence of schizophrenia, the age at onset curve, the age-
and sex-specific morbid risk, the morbidity risk for
specified biological relatives of schizophrenia probands, the
outcome of dual matting of individuals with psychoses, and
the data on reduced fertility of person with schizophrenia.6
Estimate of incidence and prevalence of
Schizophrenia depends on the criteria for diagnosis and the
population surveyed. Disorder of schizophrenia emanates
from a concept - which might be narrow or broad. Literature
is replete with examples - how the diagnostic conventions
were different in United States and United Kingdom. Cross
country studies, using operational diagnostic criteria have
been able to answer some of the questions. 
A World Health Organization’s study of ten
countries found a rather consistent annual inception rate for
schizophrenia ranging from 0.07 per 1000 in Aarhus,
Denmark, to 0.14 per 1000 in Nottingham, United Kingdom
Table 1. Three features of schizophrenia.
1. The presence of specific types of delusions or hallucinations or
thought disorder, e.g. Schneider's first rank symptoms.
2. The absence of primary mood change.
3. Chronic deterioration of function.
Table 2. Schneider's 'symptoms of the first rank'4
1. Hearing one's thoughts spoken aloud in one's head. 
2. Hearing voices arguing.
3. Hearing voices that comment on what one is doing.
4. Experiences of bodily influence (that bodily functions are affected
by an outside agency).
5. Experiences that one's thoughts are withdrawn or that thoughts are
inserted into one's mind.
6. Thought diffusion or the experience that one's thoughts are
broadcast to other.
7. Delusional perception (the attribution of special significance to a
particular perception).
8. Feelings or volitions experienced as imposed on the patient by
others.
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(Jablensky et al. 1992).7 The annual incidence is probably
between 0.1 and 0.5 per 1000 population. The lifetime risk
of developing schizophrenia is probably between 7.0 and
9.0 per 1000. The point prevalence of schizophrenia in
European countries is probably between 2.5 and 5.3
per1000 (Jablensky). Collaborative studies of World Health
Organization have shown that prevalence of schizophrenia,
when assessed in comparable ways, is similar in different
countries.
Concept of Schizophrenia
It is important to understand that current concept of
schizophrenia is based on phenomenological symptoms
elicited by detailed psychiatric interview. This is based on
Kraeplin's delineation of Dementia praecox and Manic-
depressive illness from functional psychosis. Historically,
the psychosis has been divided into two broad groups:
organic (e.g. Alzheimer's disease, epileptic psychosis), and
functional psychosis. The historical basis of this division
was simple, and rested on the presence of readily
identifiable brain pathology or a well-documented
electrophysiological or metabolic disturbance in the organic
psychosis. Advances in imaging techniques have improved
physicians' ability to detect subtle pathology where none
was previously suspected; therefore, the concept and
practice of assigning syndrome like schizophrenia to the
category of functional psychosis is obsolete. 
Almost half a century ago Longo (1952) wrote that
"it is uncontroversial that in the brain of schizophrenics
have been found different kind of histopathologic
alterations; however these alterations cannot be considered
rigorously specific of the disease but they are unequivocal
evidence of an ongoing organic process. Therefore,
schizophrenia is not to be considered any more a
psychodegenerative or psychogenic illness but a true
organic disease of the nervous system".8
This is another sense in which history of schizophrenia
is at odds with rest of the medicine: the fundamental
conceptual framework within which schizophrenia research
has been conducted. i.e. the Kraepelinian dichotomy of  major
psychoses, has hardly been modified since its inception. Its
essential features are present in ICD-10 (WHO, 1993) and
DSM-IV (APA, 1994). Prominent researchers and teachers
indicate an allegiance to this "neo-Kraepelinians' school of
thought.  However, it is generally accepted that there is no
single test or procedural rule to establish the validity of disease
concept or of a diagnostic classification in psychiatry
(Kendell, 1975).9 The acceptance of a particular diagnostic
concept or a classification scheme is usually based on the
interpretation of converging evidence from multiple sources,
including descriptive psychopathology, neuropathology,
pathophysiology, genetics and epidemiology. This process
bears a similarity to the way that 'paradigms' evolve in science
(Kuhn, 1962).10
After discussing the recurrent themes and conceptual
issues in the nosology of schizophrenia, let us now go
beyond conventional boundaries of disciplines in medicine,
in order to explore the issues pertinent to research.   
Cognitive abnormalities in schizophrenia
Cognitive function in schizophrenia is characterized
by a background of generalized impairment (I.Q is
generally a standard deviation lower than expected), with
poor performance on attention, memory, abstract thinking,
spatial working memory, and executive functions. These
deficits are present at the onset of illness, persist despite
clinical improvement, and are not the result of emotional or
motivational problems. Supporting evidence is the fact that
frontal lobe injuries (particularly dorsolateral prefrontal
cortex [DLPFC]) in adult life can mimic the 'deficit
syndrome' of schizophrenia.11
In one landmark study, Crow and Done, followed up
on all of the more than 15,000 children born in UK in one
week in March 1958. Subjects were tracked from their
mother's pregnancies until the present time by health
visitors. Socially, individual (especially boys) who
experienced schizophrenia as adults were already rated by
teachers at age 7-years as manifesting more maladjustments
than peers; preschizophrenic girls were rated as more
withdrawn and depressed at age eleven. I.Q was 5 to 10
points lower than expected, and the children were readingFigure 1: Perceptual disorder, as envisioned by a patient with Schizophrenia: Painted by Dr. Ali
Wasif, consultant psychiatrist.
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impaired at age 7 years. Neurologically, these children
showed delayed development of handedness preference
even at the age of 11 years.12   
Neurological Abnormalities
Although neurological examination may reveal
minor asymmetries of reflexes in schizophrenic patients, the
conventional examination of patients with this disorder
yields rather little if one depends on data obtained with
reflex hammer, ophthalmoscope, and tuning fork, the
classic armamentaria of the neurologist. Unobtrusive
observation yield much more. 
The most consistent neurological sign beyond the
abnormalities of the mental state found in both early and
late schizophrenia are in the domain of ocular movement.
Since pseudo-Parkinsonism, induced by Neuroleptic agent,
and tardive dyskinesias following prolonged use or
withdrawal of such agents may be associated with eye signs,
neurological evaluation should precede initiation of drug
treatment
Ocular signs
Absence and avoidance of eye contact and staring
for long periods into space are the most common ocular
signs observed in schizophrenic patients. Similar staring is
commonly observed as the very first indication of a seizure
arising in the amygdala in man, but may also be the only
sign of petit mal epilepsy. In the latter, in contrast to
amygdala seizures and schizophrenia, a characteristic
cortical EEG discharge is always present. 
Most normal adults blink six to 12 times per minute.
Nearly one-half of the patients with acute untreated
schizophrenia have decreased, increased, or paroxysmal
bouts of rapid blinking. In patients with chronic
schizophrenia, steady blinking at 60 to 80 times a minute is
not uncommon. This is in contrast to psychomotor epilepsy,
during which similar episodes of blinking may occur. Such
events can be readily interrupted in schizophrenic
patients.13
It is of interest to note that blink reflex to even the
first glabellar tap is often absent in acute untreated
schizophrenics. In contrast, patients with central DA
depletion, or patients receiving Neuroleptic DA-blocking
agents, usually fail to habituate the glabellar reflex and
display untiring blinks to repeated glabellar taps. Since
persistence of the blink reflex (but decreased on absent
spontaneous blinking) is usually an early index of DA
depletion or blockade, absence of the glabellar reflex prior
to treatment may be sign of DA hypersensitivity or
hyperactivity in systems inhibiting the blink reflex.14
Neurological Soft Signs
Neurological soft signs refer to subtle neurological
abnormalities comprising deficits in sensory integration,
motor coordination, and sequencing of complex motor acts.
A considerable body of research has established that
neurological soft signs are prevalent in schizophrenic
patients, including first-episode cases, than in health
subjects. Studies with Neuroleptic-naïve first episode
patients have demonstrated that neurological soft signs are
present before medication exposure, thus they are thought to
be an intrinsic feature of schizophrenia. This notion is
supported by findings of neurological soft signs in high-risk
subjects (i.e., relatives of schizophrenic patients and
unaffected co-twins of monzygotic twin pairs discordant for
schizophrenia). Studies generally found that relatives take
an intermediate position between healthy and schizophrenic
subjects.15-17
Structural Brain changes
Modern neuroimaging techniques have shown that
virtually every brain region is affected in schizophrenia.
Both chronic and first-episode, undedicated patients show
widespread, if small, alterations in ventricular size and
cortical grey matter. Compared with approximately 5%
overall grey matter alterations, schizophrenic patients
manifest more disproportionate local brain changes,
generally in the range of 15%, in the mesial temporal,
temporal neocortical, prefrontal, and parietal regions, with
possible alterations in thalamus, basal ganglia and
cerebellum.18-20 Many of the prominent volume changes
and asymmetry disturbances in schizophrenia may lie
within the heteromodal association neocortex, a neocortical
system that includes the planum temprale, DLPFC, Broca's
area, and inferior parietal lobule.21-24
Beyond boundaries: Research issues 
Traditionally, schizophrenia is divided in to five sub-
types based on the phenomenological symptoms. This
categorization does have its utility in being able to predict
treatment and prognosis. However, the major stumbling
block for researchers may be the definition of disease
phenotype. Though the classical clinical picture of
schizophrenia based on delusions and hallucinations can be
vivid, one contributing factor to the failure to identify a
susceptible gene may be that classical symptoms-based
disease phenotype is to narrowly defined and too
heterogeneous and classical disease phenotype are not
stable over time.  This problem led many researchers to
propose employment of heritable physiological or
neurobiological traits, correlated with the disease as the
phenotype. Such intermediate or endo-phenotypes, some
times referred as biomarkers, are proposed to have
Vol. 58, No. 3, March 2008 136
simplistic utility, improved operational definitions, and for
some, more objective diagnosis.25
Although this proposition is still in its infancy, an
emerging consensus among investigators is that the most
useful candidate biological marker for schizophrenia are
those that are more frequent in patients than control
population; that re stable over time and insensitive to age,
gender, and medication status; that are more frequent in
non-schizophrenic members of multiple affected families
than control populations. Possible candidates for biological
markers include abnormalities on structural neuro-imaging,
cognition (impairment in attention), eye tracking, event
related potentials and minor physical abnormalities, traits
that are apart from last mentioned appear to normally be
under genetic control (e.g. twin studies).26-28
Conclusion
Much of the current research-work in to biological
basis of mental disorders is predicted on implicit concept of
disease - that is less critical and sophisticated as it should
be. However conceptualization of mental illnesses in the
early part of last century was conscious of this dilemma. We
find a useful reminder in Jasper's dictum that, in psychiatry,
"the idea of the disease entity is in truth an idea in Kant's
philosophical sense…the concept of an objective which
cannot reach…but all the same it indicates the path for
fruitful research and supplies a valid point of orientation for
particular empirical investigation".6
Reviewing the work of Kraepelin, one comes to the
conclusion that he was anything but dogmatic in his view -
unlike Sigmund Freud. He also had the intellectual integrity
to accept many of the arguments of his critics. In one of this
last articles, "Pattern of mental disorders", Kraepelin (1920)
took a radical departure from his earlier views, stating that
"it is natural to turn away from arranging illnesses in orderly
well-defined groups and to set ourselves instead the
undoubtedly higher and more satisfying goal of
understanding their essential structure". No summary could
do justice to this profound reflection on the cardinal
conceptual issue of psychiatry. 
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